Effects of different types of radiation therapy on cardiac-specific death in patients with thyroid malignancy

Ruxin Wang, Haowen Ye, Ying Wang, Li Ma, Jinjing Wei, Xiaofang Zhang, Lihong WangFrontiers in Cardiovascular Medicine 2022 · DOI

TL;DR

This study investigated the impact of different types of radiation therapy (RT) on cardiac-specific death in thyroid cancer patients. Surprisingly, certain RT modalities, specifically radioactive implants and radioisotopes, were associated with a lower risk of cardiac death, challenging the conventional view of RT as solely detrimental to the heart. These findings suggest that RT might have complex, modality-dependent effects on cardiovascular health in this patient population.

What Problem Does This Paper Address?

Radiation therapy (RT) is a common treatment for thyroid cancer. However, the thyroid gland's proximity to the heart raises concerns about potential radiation-induced cardiac damage and subsequent cardiac-specific mortality. While RT is known to increase cardiovascular risks in some cancer types, its specific impact on cardiac death in thyroid cancer, particularly concerning different RT techniques, has not been thoroughly elucidated. This paper aims to fill this knowledge gap by exploring the relationship between various RT modalities and cardiac-specific death in a large cohort of thyroid cancer patients.

Methods

The researchers utilized a retrospective cohort study design, drawing data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database. They identified 201,346 patients diagnosed with malignant thyroid tumors between 2000 and 2019. To account for potential biases in baseline characteristics between patients who received RT and those who did not, Propensity Score Matching (PSM) was employed. Statistical analysis involved both COX proportional hazards and Fine-Gray competing risk regression models to identify factors influencing cardiac-specific death.

Datasets

The study used data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database, accessed via SEER*Stat software. This is a large, population-based registry of cancer patient demographics and clinical information across multiple US regions. No new datasets were introduced.

Key Insights and Ideas

  • RT's Dual Nature: The study challenges the simplistic view of RT as uniformly harmful to the heart. It suggests that specific RT modalities might offer a protective effect against cardiac-specific death, potentially through mechanisms that are not yet fully understood.
  • Modality Matters: The type of radiation therapy appears to be a critical factor. Radioactive implants and radioisotopes showed a significant association with reduced cardiac-specific death risk, while other methods had less clear or no significant impact.
  • Complex Interactions: The findings highlight the intricate interplay between RT, patient demographics, and cancer characteristics in determining cardiac outcomes. Factors like ethnicity, sex, marital status, income, and cancer stage all play a role.

Key Results

  • Overall RT Effect: Compared to patients who did not receive RT, those who underwent RT showed a lower risk of cardiac-specific death (HR = 0.771, p < 0.001) after PSM.
  • Specific RT Modalities:
    • Radioisotopes: Associated with a significantly lower risk of cardiac-specific death (HR = 0.764, p < 0.001).
  • Radioactive Implants: Also associated with a significantly lower risk (HR = 0.596, p = 0.047).
  • Beam Radiation: Showed a trend towards lower risk (HR = 0.829, p = 0.179) but did not reach statistical significance in the COX model after PSM. However, in the Fine-Gray model, it was a significant protective factor (HR = 0.619, p = 0.001).
  • Combination of beam with implants/isotopes and NOS method: Did not significantly increase the risk of cardiac-specific death.
  • Protective Factors: Asian or Pacific Islander ethnicity, female sex, married or DSW marital status, higher income (≥$75,000), localized or regional combined summary stage, and later year of diagnosis were associated with a lower risk of cardiac-specific death.
  • Risk Factors: Older age at diagnosis, African ethnicity, non-Hispanic ancestry, and AJCC stage IV were associated with a higher risk of cardiac-specific death.

Limitations and Future Work

The authors acknowledge a significant limitation: the SEER database does not capture detailed clinical information such as specific cardiovascular risk factors (e.g., hypertension, diabetes), comorbidities, or precise causes of cardiac death. This prevents definitive conclusions about the mechanisms behind the observed associations. Future work should focus on randomized controlled trials to confirm these findings and further investigate the underlying biological mechanisms responsible for the differential effects of various RT modalities on cardiac health.

Summary updated

Abstract

Radiation therapy (RT) is one of the common and widely used treatment method for thyroid tumors. Considering that the thyroid is located close to the heart, the radiation generated during the treatment of thyroid tumors may have an adverse greater impact on the heart. This study is to explore the influencing factors, especially additional effects of RT, on cardiac-specific death among patients with malignant thyroid tumors. Collecting information from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database using SEER*Stat. Patients with malignant thyroid tumors were searched, whether receiving RT or not. Ultimately, 201, 346 eligible patients were included. Propensity Score Matching (PSM) was used to minimize bias of baseline characteristics by adjusting for confounding factors. COX (proportional hazards) and fine-gray (competing risk) model regression analysis were used to explore the effects of various influencing factors on cardiac-specific death. The present analysis showed that, compared with non-RT, RT based upon radioactive implants and beam radiation were associated with lower risk of cardiac-specific death in patients with thyroid malignancy, beam radiation therapy may had a similar effect. Besides, the remaining RT methods did not significantly increase the risk of cardiac-specific death. In addition, Asian or Pacific Islander ethnicity, female sex, marital status, combined summary stage (localized, regional, and distant), high-income, and later year of diagnosis were associated with lower risk of cardiac-specific death. While older age of diagnosis, African ethnicity, non-Hispanic ancestry, and derived AJCC stage (IV) were risk factors for cardiac-specific death. These results help to identify the factors influencing cardiac-specific death among patients with thyroid malignancies. Furthermore, it may helps to improve the clinical application of RT without too much concern about adverse cardiac effects.
BibTeX
@inproceedings{wang2022effects,
  author = {Ruxin Wang and Haowen Ye and Ying Wang and Li Ma and Jinjing Wei and Xiaofang Zhang and Lihong Wang},
  title = {{Effects of different types of radiation therapy on cardiac-specific death in patients with thyroid malignancy}},
  booktitle = {Frontiers in Cardiovascular Medicine},
  year = {2022},
  doi = {10.3389/fcvm.2022.996732},
}
Figure